The Enormous Promise and Peril of Bioengineering's Pandora's Box

We're standing on the threshold of extraordinary capability in synthetic biology. CRISPR-Cas9, the genome editing technique discovered in 2014, is at the forefront of this newfound potential for innovation. These advancements provide an opportunity to solve problems in food supply, disease, genetics, and--the most tantalizing and forbidden of prospects--modifying the human genome. Doing so would […]